Clinical breast examination: lump, pain and benign changes
EBM Guidelines
Jan 15, 2022 • Latest change Jan 13, 2025
Table of contents
Extract
- All palpated lumps and suspicious visual changes must be further examined.
- In the investigation of palpable lesions, a triple diagnostic approach is used: clinical examination, imaging studies and needle biopsy (cytological/histological).
- Benign breast changes are common; fibrocystic changes are found in every fourth woman in fertile age.
- Fibrocystic changes are not associated with increased risk of breast cancer.
- Breast cancer risk is to some extent increased in a radiologically dense breast tissue.
- Breast cancer risk is 1.5–2.0-fold in ductal hyperplasia, lobular hyperplasia (without atypia), sclerosing adenosis, diffuse papillomatosis, complex fibroadenoma and radial scar changes.
Read full article of Clinical breast examination: lump, pain and benign changes
Search terms
Breast, Bromocriptine, Danazol, Gynaecology, N63, N64.4, Neoplastic diseases, Surgery, breast examination, breast lump, skin retraction